Medicamen Biotech Limited — Dividend/Bonus, 12-08-2025: Record Date

Medicamen Biotech's Board approved a final dividend of Re. 1 per share (10%) for FY24-25. This dividend is subject to shareholder approval at the AGM on September 26, 2025. For dividend eligibility, the company's share transfer books will close from September 19, 2025, to September 25, 2025. Investors must hold shares by September 18, 2025, to qualify for the payout.